Sai Life Sciences, a global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch Day…
Read More

Sai Life Sciences, a global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch Day…
Read More
A groundbreaking strategic partnership has been announced between OpenBench, a pioneer in AI-driven drug discovery, and Concept Life Sciences, a…
Read More
Gilead Sciences has officially completed its acquisition of Tubulis, a prominent German biotechnology firm specializing in the development of next-generation…
Read More
Gilead Sciences has announced a significant commitment to global health, pledging over 400,000 doses of its vital antifungal medication, AmBisome…
Read More
Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
Sai Life Sciences, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
Gilead Sciences has commenced 2026 with a demonstrably strong first quarter, reporting significant revenue growth primarily fueled by its leading…
Read More
Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly anticipated Biotech Pitch…
Read More
In the rapidly evolving landscape of life sciences, Polymerase Chain Reaction (PCR) stands as a foundational molecular biology technique, indispensable…
Read More
Sai Life Sciences recently convened its highly anticipated Biotech Pitch Day 2026 at its strategically located Boston-area site, gathering a…
Read More